Literature DB >> 7685179

Vimentin in oral squamous cell carcinoma.

V C de Araujo1, D S Pinto Júnior, S O de Sousa, F D Nunes, N S de Araujo.   

Abstract

The relationship between the histological grading of malignancy and the expression of vimentin and cytokeratin was studied in 43 cases of oral squamous cell carcinoma. Immunohistochemical analysis was carried out with the avidin-biotin method using monoclonal antibody anti-vimentin, and the peroxidase anti-peroxidase method using the polyclonal antibody anti-cytokeratin. All cases were classified according to the histological malignancy grading system proposed by Anneroth. All of the carcinomas were found to express cytokeratin, while 60.4% expressed vimentin. Vimentin was particularly noted in all tumors scored to have highly malignant cells.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7685179     DOI： 10.1007/bf00179308

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN： 0937-4477            Impact factor:   2.503


  28 in total

Review 1.  Diagnostic immunohistochemistry of human tumors. An interim evaluation.

Authors:  R A Erlandson
Journal:  Am J Surg Pathol       Date:  1984-08       Impact factor: 6.394

2.  Differential diagnosis of human carcinomas, sarcomas and their metastases using antibodies to intermediate-sized filaments.

Authors:  F Ramaekers; J Puts; A Kant; O Moesker; P Jap; P Vooijs
Journal:  Eur J Cancer Clin Oncol       Date:  1982-12

3.  Vimentin as a marker of myoepithelial cells in salivary gland tumors.

Authors:  V C de Araújo; N S de Araújo
Journal:  Eur Arch Otorhinolaryngol       Date:  1990       Impact factor: 2.503

4.  The histological grading of neoplasms.

Authors:  D E Henson
Journal:  Arch Pathol Lab Med       Date:  1988-11       Impact factor: 5.534

5.  An electron microscopic histochemical study of the histogenesis of major salivary gland pleomorphic adenoma.

Authors:  R M Lam
Journal:  Ultrastruct Pathol       Date:  1985       Impact factor: 1.094

6.  Cellular origin and differentiation of renal carcinomas. A fluorescence microscopic study with kidney-specific antibodies, antiintermediate filament antibodies, and lectins.

Authors:  H Holthöfer; A Miettinen; R Paasivuo; V P Lehto; E Linder; O Alfthan; I Virtanen
Journal:  Lab Invest       Date:  1983-09       Impact factor: 5.662

7.  Malignancy grading of squamous cell carcinoma in the floor of the mouth related to clinical evaluation.

Authors:  G Anneroth; J G Batsakis; M Luna
Journal:  Scand J Dent Res       Date:  1986-08

8.  Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinomas.

Authors:  G Anneroth; J Batsakis; M Luna
Journal:  Scand J Dent Res       Date:  1987-06

9.  Histological grading of malignancy in squamous cell carcinoma of the oral tongue.

Authors:  L E Holm; P G Lundquist; C Silfverswärd; A Sobin
Journal:  Acta Otolaryngol       Date:  1982 Jul-Aug       Impact factor: 1.494

10.  Mitosis and intermediate-sized filaments in developing skeletal muscle.

Authors:  H Ishikawa; R Bischoff; H Holtzer
Journal:  J Cell Biol       Date:  1968-09       Impact factor: 10.539
View more
  11 in total

1.  Effect of the miR-96-5p inhibitor and mimic on the migration and invasion of the SW480-7 colorectal cancer cell line.

Authors:  Pei Yuan He; Wai Kien Yip; Mohd Faisal Jabar; Norhafizah Mohtarrudin; Noraini Mohd Dusa; Heng Fong Seow
Journal:  Oncol Lett       Date:  2019-06-18       Impact factor: 2.967

2.  Cytokeratin 8/18 expression indicates a poor prognosis in squamous cell carcinomas of the oral cavity.

Authors:  Thomas Fillies; Richard Werkmeister; Jens Packeisen; Burkhard Brandt; Philippe Morin; Dieter Weingart; Ulrich Joos; Horst Buerger
Journal:  BMC Cancer       Date:  2006-01-13       Impact factor: 4.430

3.  Study of β-catenin, E-cadherin and vimentin in oral squamous cell carcinoma with and without lymph node metastases.

Authors:  Partheeban Balasundaram; Manoj Kumar Singh; Amit Kumar Dinda; Alok Thakar; Rajni Yadav
Journal:  Diagn Pathol       Date:  2014-07-21       Impact factor: 2.644

4.  Vimentin and Non-Muscle Myosin IIA are Members of the Neural Precursor Cell Expressed Developmentally Down-Regulated 9 (NEDD9) Interactome in Head and Neck Squamous Cell Carcinoma Cells.

Authors:  Martina Semelakova; Stèphane Grauzam; Prabhakar Betadthunga; Jessica Tiedeken; Sonya Coaxum; David M Neskey; Steven A Rosenzweig
Journal:  Transl Oncol       Date:  2018-09-26       Impact factor: 4.243

Review 5.  Biomarker Potential of Vimentin in Oral Cancers.

Authors:  Saie Mogre; Vidhi Makani; Swapnita Pradhan; Pallavi Devre; Shyam More; Milind Vaidya; Crismita Dmello
Journal:  Life (Basel)       Date:  2022-01-20

6.  2D-DIGE-Based Proteomic Profiling with Validations Identifies Vimentin as a Secretory Biomarker Useful for Early Detection and Poor Prognosis in Oral Cancers.

Authors:  Ananthi Sivagnanam; Vidyarani Shyamsundar; Pallavi Kesavan; Arvind Krishnamurthy; Soundara Viveka Thangaraj; Divyambika Catakapatri Venugopal; Hemashree Kasirajan; Pratibha Ramani; Vinutha Rachapudi Sarma; Vijayalakshmi Ramshankar
Journal:  J Oncol       Date:  2022-04-22       Impact factor: 4.501

7.  Analysis of metallothionein and vimentin immunoreactivity in pharyngeal squamous cell carcinoma and its microenvironment.

Authors:  Magdalena Dutsch-Wicherek; Agata Lazar; Romana Tomaszewska; Wojciech Kazmierczak; Lukasz Wicherek
Journal:  Cell Tissue Res       Date:  2013-02-09       Impact factor: 5.249

8.  Epithelial-mesenchymal transition-like events in vulvar cancer and its relation with HPV.

Authors:  I S Rodrigues; A M Lavorato-Rocha; B de M Maia; M M A Stiepcich; F M de Carvalho; G Baiocchi; F A Soares; R M Rocha
Journal:  Br J Cancer       Date:  2013-06-18       Impact factor: 7.640

9.  Clinicopathological Significance of Vimentin and Cytokeratin Protein in the Genesis of Squamous Cell Carcinoma of Cervix.

Authors:  Nazik Elmalaika O S Husain; Ali Yousif Babiker; Aqel S Albutti; Mohammed A Alsahli; Salah M Aly; Arshad H Rahmani
Journal:  Obstet Gynecol Int       Date:  2016-04-14

10.  Identification of miR-515-3p and its targets, vimentin and MMP3, as a key regulatory mechanism in esophageal cancer metastasis: functional and clinical significance.

Authors:  Hui-Fang Hu; Wen Wen Xu; Wei-Xia Zhang; Xin Yan; Yang-Jia Li; Bin Li; Qing-Yu He
Journal:  Signal Transduct Target Ther       Date:  2020-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.